Skip to content

i-80 Gold IAUX Warrant and stock option exercises

Warrant and stock option exercises at other companies

Amprius Technologies logo
Amprius TechnologiesAMPX
$1.9M
Unusual Machines logo
Unusual MachinesUMAC
$3.4M+39.3%
Personalis, Inc. logo
Personalis, Inc.PSNL
$4.61M
NewAmsterdam Pharma Company logo
NewAmsterdam Pharma CompanyNAMS
$651K+256%
OneSpaWorld Holdings Limited logo
OneSpaWorld Holdings LimitedOSW
$0
Noble Corporation logo
Noble CorporationNE
$2.57M+6,661%

Other financials

Income statement

See full
Revenue$52.4M+273%
Gross profit$16.6M+405%
Operating income-$21.8M-38.3%
Net income-$78.6M-90.8%
EPS (diluted)-$0.09+10.0%

Balance sheet

See full
Cash & equivalents$555.8M+921%
Total debt$441.8M+123%
Total equity$298.9M-6.0%
Total assets$1.2B+78.5%

Cash flow

See full
Operating cash flow-$45.1M-98.6%
CapEx$11.9M+3,230%
Free cash flow-$56.9M-147%

Valuation

See full
Market cap$1.2B+113%
Enterprise value$1.08B+53.4%
P/S-1.1×

Profitability

See full
Gross margin19.9%
Operating margin-97.7%-27.1pp
Net margin-176.9%-41.6pp
FCF margin-95.2%-24.5pp

Returns & leverage

See full
Return on equity-76.6%+273pp
Debt / equity1.5×+0.9×
Current ratio9.5×+8.9×

Where this comes from

Reported directly by i-80 Gold in its filing.

Tagged under the XBRL concept iaux:ProceedsFromWarrantAndStockOptionExercises.

The official record: i-80 Gold’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about i-80 Gold's warrant and stock option exercises.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is i-80 Gold's warrant and stock option exercises?
i-80 Gold (IAUX) reported warrant and stock option exercises of $10.2M in Q1 2026.
How has i-80 Gold's warrant and stock option exercises changed year-over-year?
i-80 Gold's warrant and stock option exercises increased by 127412.5% year-over-year, from $8K to $10.2M.
What does warrant and stock option exercises mean?
This represents the cash inflows received by the company when holders of warrants and stock options exercise their rights to purchase common shares. It serves as a source of non-dilutive or equity-based financing that strengthens the company's cash position. Investors monitor this to understand the potential impact of equity dilution and the company's ability to generate capital from existing incentive structures.